Novo Nordisk’s Wegovy subsidy application
Photo: Lise Åserud/NTB/TT

Novo Nordisk’s Wegovy subsidy application for children and teens rejected again

Earlier this year, Danish Novo Nordisk was denied a subsidy for its obesity drug Wegovy. Now the application for children and young people has also been denied, the pharmaceutical giant says.

Advertisement

Novo Nordisk submitted the new application in June, but the Dental and Pharmaceutical Benefits Agency (TLV) says it cannot take a position on it because an appeal regarding the previous application has still not been decided by the Administrative Court.

The company is "surprised and disappointed".

"We applied again for a subsidy based on our own and the world's very strong desire to help the group of children and young people with severe obesity," says Helena Anderin, Director of Social Policy at Novo Nordisk Sweden, in a press release, adding that TLV also made it clear that it requested a renewed application for children and young people.

In this story
AuthorTT News AgencyEnglish edition by Sweden Herald, adapted for our readers
Was this useful?

What do you think?

Keep readingmore from Sweden

All